China Health Group Full Year 2024 Earnings: HK$0.084 loss per share (vs HK$0.099 loss in FY 2023)

China Health Group (HKG:673) Full Year 2024 Results

Key Financial Results

• Revenue: HK$59.9m (down 22% from FY 2023).
• Net loss: HK$40.2m (loss narrowed by 4.4% from FY 2023).
• HK$0.084 loss per share (improved from HK$0.099 loss in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

China Health Group's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for China Health Group (2 are concerning) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com